Assessing residual insulin time
US8439897B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Nov 4, 2008 |
| Grant date | May 14, 2013 |
| Priority date | — |
| Expiry date | May 30, 2029 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16H40/63
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Methods, systems and devices for assessing residual insulin time of a patient are provided. In one embodiment, the method and the device can be implemented by receiving a confirmation that an insulin dose has been administered to the patient; repetitively receiving a value corresponding to the patient's blood glucose level; identifying at least two consecutively received values based on a predetermined criteria; and, selecting the residual insulin time corresponding to a time period between the confirmation that the insulin dose has been administered and a time corresponding to the identification of the at least two consecutively received values.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.